Improving the spontaneous reporting of suspected adverse drug reactions: An overview of systematic reviews

被引:1
|
作者
Routledge, Philip Alexander [1 ]
Bracchi, Robert [2 ]
机构
[1] Cardiff Univ, Sch Med, Cardiff, Wales
[2] Univ Hosp Llandough, All Wales Therapeut & Toxicol Ctr, Llandough, Wales
关键词
adverse drug reaction reports; overview; systematic reviews; CLUSTER-RANDOMIZED TRIAL; TIME-SERIES ANALYSIS; THROMBOTIC MICROANGIOPATHY; EDUCATIONAL INTERVENTION; PHARMACOVIGILANCE; STRATEGIES; PHYSICIANS; PROGRAM;
D O I
10.1111/bcp.15791
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
AimTo conduct an overview of systematic reviews examining interventions to stimulate spontaneous reporting of suspected adverse drug reactions (ADRs) by healthcare professionals (HCPs) and/or patients/carers. MethodsSystematic reviews published since 1 January 2000 were identified and the included publications categorized in relation to the 4Es (education, engineering, economics and enforcement). ResultsAlmost all studies were aimed at HCPs. Educational initiatives were most often used and, in most studies, were associated with improvements in quantity and/or quality of reports, at least in the short term. Lectures/presentations and regular reminders (eg, verbal or by e-mail) were the educational methods most often identified by systematic reviews. Engineering initiatives were also generally effective, including improving the availability of reporting forms, electronic ADR reporting, modification of reporting procedures/policies or the reporting form and assistance to complete the form. Evidence for the benefit of economic incentives (eg, monetary rewards, lottery tickets, days off work, "giveaways" and educational credits) was often clouded by the potential effects of other concomitant initiatives, and any possible associated improvements often disappeared rapidly after incentives were discontinued. ConclusionEducational and engineering strategies appear to be the interventions most often associated with improvements in reporting rates by HCPs, at least in the short to medium term. However, the evidence for sustained impact is weak. The available data were insufficient to clearly identify the separate impact of economic strategies. Further work is also needed to examine the effects of these strategies on reporting by patients, carers and the public.
引用
收藏
页码:2377 / 2385
页数:9
相关论文
共 50 条
  • [1] SPONTANEOUS REPORTING OF SUSPECTED ADVERSE DRUG-REACTIONS
    WATT, AH
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 33 (04) : 461 - 462
  • [2] SPONTANEOUS REPORTING OF SUSPECTED ADVERSE DRUG-REACTIONS - A REPLY
    TUBERT, P
    BEGAUD, B
    HARAMBURU, F
    PERE, JC
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 33 (04) : 462 - 462
  • [3] Who reports suspected adverse drug reactions to the spontaneous reporting system in Sweden?
    Jacobsson, Ingela
    Boman, Marit Danell
    Joensson, Anna K.
    Haegg, Staffan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S177 - S177
  • [4] Improving Spontaneous Reporting of Adverse Drug Reactions: A Trial among Pharmacists
    Vaz, I
    Herdeiro, M. T.
    Polonia, J.
    Figueiras, A.
    DRUG SAFETY, 2008, 31 (10) : 899 - 900
  • [5] Improving Spontaneous Reporting of Adverse Drug Reactions: A Trial among Pharmacists
    I. Vaz
    M. T. Herdeiro
    J. Polonia
    A. Figueiras
    Drug Safety, 2008, 31 : 885 - 885
  • [6] Suspected Adverse Drug Reactions in Children: A Descriptive Study of the Italian Spontaneous Reporting System
    Ferrajolo, C.
    Capuano, A.
    Rossi, F.
    Moretti, U.
    Trifiro, G.
    Santuccio, C.
    DRUG SAFETY, 2013, 36 (09) : 882 - 882
  • [7] Spontaneous reporting of adverse drug reactions by nurses
    Bäckström, M
    Mjörndal, T
    Dahlqvist, R
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (08) : 647 - 650
  • [8] SPONTANEOUS REPORTING OF ADVERSE DRUG-REACTIONS
    RAWLINS, MD
    QUARTERLY JOURNAL OF MEDICINE, 1986, 59 (230): : 531 - 534
  • [10] The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database
    Castillon, Genaro
    Salvo, Francesco
    Moride, Yola
    DRUG SAFETY, 2019, 42 (01) : 27 - 34